Continue to meet or exceed healthcare partners’ expectations by providing on-time test results approximately 92 percent of the time.
In January, CTS is incorporated as a non-profit organization owned by Vitalant and OneBlood (formerl...
CTS Research Consortium was established to further CTS’s leadership in infectious disease research....
In October, due to demand from existing healthcare partners, CTS began testing blood donors for anti...
In August CTS begins source plasma testing as a new line of business to one of the largest plasma fr...
Transitioned all 6 CTS labs from an investigational new drug (IND) to a licensed Zika test, and anno...
CTS Tampa lab implements Dengue testing on behalf of a healthcare partner in an endemic area.